China · Delayed Price · Currency is CNY Huaren Pharmaceutical Statistics
Total Valuation
SHE:300110 has a market cap or net worth of CNY 3.72 billion. The enterprise value is 4.90 billion.
| Market Cap | 3.72B |
| Enterprise Value | 4.90B |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300110 has 1.18 billion shares outstanding. The number of shares has increased by 0.14% in one year.
| Current Share Class | 1.18B |
| Shares Outstanding | 1.18B |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 9.95% |
| Float | 886.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.80 |
| PB Ratio | 4.02 |
| P/TBV Ratio | 10.13 |
| P/FCF Ratio | 13.31 |
| P/OCF Ratio | 12.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.18, with an EV/FCF ratio of 17.52.
| EV / Earnings | -10.59 |
| EV / Sales | 3.69 |
| EV / EBITDA | 18.18 |
| EV / EBIT | 30.46 |
| EV / FCF | 17.52 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.40.
| Current Ratio | 0.82 |
| Quick Ratio | 0.59 |
| Debt / Equity | 1.40 |
| Debt / EBITDA | 4.79 |
| Debt / FCF | 4.62 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.64% and return on invested capital (ROIC) is 7.97%.
| Return on Equity (ROE) | -39.64% |
| Return on Assets (ROA) | 3.23% |
| Return on Invested Capital (ROIC) | 7.97% |
| Return on Capital Employed (ROCE) | 11.19% |
| Weighted Average Cost of Capital (WACC) | 4.88% |
| Revenue Per Employee | 533,098 |
| Profits Per Employee | -185,857 |
| Employee Count | 2,491 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.21 |
Taxes
In the past 12 months, SHE:300110 has paid 2.01 million in taxes.
| Income Tax | 2.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.62% in the last 52 weeks. The beta is 0.42, so SHE:300110's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +8.62% |
| 50-Day Moving Average | 3.21 |
| 200-Day Moving Average | 3.35 |
| Relative Strength Index (RSI) | 48.14 |
| Average Volume (20 Days) | 46,347,268 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300110 had revenue of CNY 1.33 billion and -462.97 million in losses. Loss per share was -0.39.
| Revenue | 1.33B |
| Gross Profit | 482.45M |
| Operating Income | 160.96M |
| Pretax Income | -457.12M |
| Net Income | -462.97M |
| EBITDA | 266.90M |
| EBIT | 160.96M |
| Loss Per Share | -0.39 |
Balance Sheet
The company has 185.49 million in cash and 1.29 billion in debt, with a net cash position of -1.11 billion or -0.94 per share.
| Cash & Cash Equivalents | 185.49M |
| Total Debt | 1.29B |
| Net Cash | -1.11B |
| Net Cash Per Share | -0.94 |
| Equity (Book Value) | 925.86M |
| Book Value Per Share | 0.72 |
| Working Capital | -242.62M |
Cash Flow
In the last 12 months, operating cash flow was 307.83 million and capital expenditures -28.03 million, giving a free cash flow of 279.79 million.
| Operating Cash Flow | 307.83M |
| Capital Expenditures | -28.03M |
| Depreciation & Amortization | 105.94M |
| Net Borrowing | -253.36M |
| Free Cash Flow | 279.79M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 36.33%, with operating and profit margins of 12.12% and -34.86%.
| Gross Margin | 36.33% |
| Operating Margin | 12.12% |
| Pretax Margin | -34.42% |
| Profit Margin | -34.86% |
| EBITDA Margin | 20.10% |
| EBIT Margin | 12.12% |
| FCF Margin | 21.07% |
Dividends & Yields
SHE:300110 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.14% |
| Shareholder Yield | -0.14% |
| Earnings Yield | -12.43% |
| FCF Yield | 7.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 31, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | May 31, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |